I am relatively new to this stock, have been buying in the mid-8s these last few months. With respect to European approval, I cannot find a PR stating that they have filed an MAA in Europe. Nor can I find any CHMP agendas that include discussion of the drug. I can only see that they have been given ATMP designation, a precursor step to the actual filing. As far as I can tell, they have not yet filed for European approval, so the approval itself is not forthcoming. Someone please set me straight, what am I missing?